Beam Therapeutics

Beam Therapeutics is a biotechnology company located in Cambridge, Massachusetts, founded in 2017. The company specializes in gene therapies and genome editing, particularly through its innovative base editing technologies. Co-founded by notable scientists in the CRISPR field, Beam Therapeutics is dedicated to developing precision genetic medicines aimed at treating serious diseases such as sickle cell disease, T-cell cancers, glycogen storage disease 1a, and Alpha-1 antitrypsin deficiency. The company’s pipeline includes investigational products like BEAM-101, which targets sickle cell disease, along with other products focused on genetic disorders. Beam Therapeutics employs various genome-editing tools, including cytosine and adenine base editors, to provide precise modifications to DNA and RNA. The company is publicly traded on NASDAQ under the ticker symbol BEAM and has raised significant funding to support its research and development efforts. With a growing team of around 483 employees, Beam Therapeutics is committed to delivering lifelong cures to patients through its cutting-edge science and collaborative partnerships.

Research Cambridge, United States ~615 employees NASDAQ: BEAM

Work at Beam Therapeutics in HR or recruiting? Claim this page

Employees
615
+3.9% in the 3 months to Sep 2026
Revenue / employee
$103K
Revenue ~$63.6M
Stock
BEAM
NASDAQ
12-month attrition
9.1%
Tech: 8%
H1B filings, FY2026
4
Sponsors visas
Open jobs
14
Last 30 days

Headcount trend

Beam Therapeutics went from 495 employees in Oct 2024 to 615 in Sep 2026. Apr to Sep 2026: 52 people joined, 16 left.

Org structure

Headcount by department

Other386
Operations91
Engineering72
Finance26
HR17
Sales15
Marketing5
Success3

Executive compensation

H-1B sponsorship

H-1B Sponsorship Limited
H-1B Filings by Department
Engineering20
Operations3
Executive2
IT1

The department split adds up all the years listed above. FY2026 alone: 4 filings.

Peer reviews

Worked with someone at Beam Therapeutics?

Anonymous peer reviews on OffTheRecord

Read or write a review

Similar companies

Hiring now

Beam Therapeutics FAQ

How many employees does Beam Therapeutics have?

Beam Therapeutics has about 615 employees, up 3.9% over the 3 months to Sep 2026.

Does Beam Therapeutics sponsor H1B visas?

Yes. Beam Therapeutics filed 4 H1B (LCA) applications in FY2026, according to the latest U.S. Department of Labor disclosures. Most of them were for Engineering roles.

What is Beam Therapeutics's revenue per employee?

Beam Therapeutics makes about $103K in revenue per employee, based on $63.58M annual revenue and 615 employees.

Is Beam Therapeutics a public company?

Yes. Beam Therapeutics is publicly traded under the ticker BEAM on NASDAQ.

Data from Company Prospectus, DOL LCA disclosures, WARN notices and 6figr salary profiles.